Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial

BACKGROUND: Preoperative treatment of resectable liver metastases from colorectal cancer (CRC) is a matter of debate. The aim of this study was to assess the feasibility and activity of bevacizumab plus FOLFIRI in this setting. METHODS: Patients aged 18–75 years, PS 0–1, with resectable liver-confin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasti, G, Piccirillo, M C, Izzo, F, Ottaiano, A, Albino, V, Delrio, P, Romano, C, Giordano, P, Lastoria, S, Caracò, C, de Lutio di Castelguidone, E, Palaia, R, Daniele, G, Aloj, L, Romano, G, Iaffaioli, R V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668480/
https://www.ncbi.nlm.nih.gov/pubmed/23558891
http://dx.doi.org/10.1038/bjc.2013.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668480/
https://www.ncbi.nlm.nih.gov/pubmed/23558891
http://dx.doi.org/10.1038/bjc.2013.140

Ejemplares similares